In Th2-high asthma, MAPK promotes Th2 cells to release IL-4, IL-5, and IL-13, stimulating IgE production, eosinophil recruitment, and airway hyperresponsiveness [47]. Here, IL5 is linked to airway hyperresponsiveness.